研究报告

菌株X3-2B和37X-3体外抑制黄嘌呤氧化酶能力及其对小鼠高尿酸血症缓解作用的研究

  • 王诗琪 ,
  • 张美枝 ,
  • 郝世奇 ,
  • 李佳让 ,
  • 李晓彤 ,
  • 王富荣 ,
  • 孙学颖 ,
  • 葛雅丽 ,
  • 赵丽华
展开
  • 1(内蒙古农业大学 食品科学与工程学院,内蒙古 呼和浩特,010020)
    2(内蒙古农业大学 职业技术学院,内蒙古 包头,014000)
    3(包头东宝生物技术股份有限公司,内蒙古 包头,014000)
第一作者:硕士研究生(赵丽华教授为通信作者,E-mail:867051675@qq.com)

收稿日期: 2023-11-06

  修回日期: 2024-01-13

  网络出版日期: 2024-11-01

基金资助

农业农村部生鲜牛羊肉加工技术集成科研基地能力建设项目(BR221028)

Ability of strains X3-2B and 37X-3 to inhibit xanthine oxidase in vitro and their mitigating effect on hyperuricemia in mice

  • WANG Shiqi ,
  • ZHANG Meizhi ,
  • HAO Shiqi ,
  • LI Jiarang ,
  • LI Xiaotong ,
  • WANG Furong ,
  • SUN Xueying ,
  • GE Yali ,
  • ZHAO Lihua
Expand
  • 1(Inner Mongolia Agricultural University, Hohhot 010020, China)
    2(College of Vocational and Technical, Inner Mongolia Agricultural University, Baotou 014000, China)
    3(Baotou Dongbao Bio-Tech Co., Ltd., Baotou 014000, China)

Received date: 2023-11-06

  Revised date: 2024-01-13

  Online published: 2024-11-01

摘要

为探究菌株X3-2B和37X-3对黄嘌呤氧化酶(xanthine oxidase,XOD)的抑制能力和对小鼠高尿酸血症(hyperuricemia,HUA)的缓解作用,利用HPLC测定菌株X3-2B和37X-3在含有黄嘌呤和XOD的培养环境中培养20、40、60、80、100 min时,培养基中黄嘌呤和尿酸(uric acid,UA)的含量;调节培养基pH和胆盐浓度,检测不同pH和胆盐浓度下的活菌数,研究菌株X3-2B和37X-3在体外对XOD的抑制能力和耐酸耐碱特性。将60只KM小鼠随机分为5组:对照组(C组)、模型组(M组)、X3-2B组(X组)、37X-3组(L组)和别嘌呤醇组(P组),除C组饲喂对照饲料外,其他各组均饲喂高嘌呤饲料。小鼠共喂养4周,每日给X组、L组和P组小鼠分别灌胃相应剂量的菌株X3-2B、37X-3和别嘌呤醇,通过对小鼠生理生化指标、肾脏病理学切片和肠道组织XOD活性分析,研究菌株X3-2B、37X-3对小鼠HUA的缓解作用。研究指出菌株X3-2B和37X-3可以有效抑制XOD催化黄嘌呤生成UA;在pH 2和胆盐添加量3 g/L时,X3-2B和37X-3的活菌数分别为6.4×107 CFU/g(X3-2B)、9.3×107 CFU/g(37X-3)和2.1×106 CFU/g(X3-2B)、2.8×106 CFU/g(37X-3);小鼠喂养4周后,X组和L组小鼠血清中UA、血尿素氮(blood urea nitrogen,BUN)和肌酐(creatinine,Cr)含量显著下降(P<0.05),肾单位结构完整,肠道组织中XOD活性被抑制(P<0.05)。得出菌株X3-2B和37X-3可以有效抑制XOD活性,减少UA生成;并且可以在HUA小鼠肠道中发挥XOD抑制功能,缓解小鼠HUA。

本文引用格式

王诗琪 , 张美枝 , 郝世奇 , 李佳让 , 李晓彤 , 王富荣 , 孙学颖 , 葛雅丽 , 赵丽华 . 菌株X3-2B和37X-3体外抑制黄嘌呤氧化酶能力及其对小鼠高尿酸血症缓解作用的研究[J]. 食品与发酵工业, 2024 , 50(20) : 145 -152 . DOI: 10.13995/j.cnki.11-1802/ts.037878

Abstract

To investigate the inhibitory ability of strains X3-2B and 37X-3 on xanthine oxidase(XOD)and their alleviating effect on hyperuricemia (HUA) in mice, this study used HPLC to determine the content of xanthine and uric acid (UA) in the medium.The strains were cultured in a medium containing xanthine and XOD for different durations (20, 40, 60, 80 and 100 min).This study also adjusted the pH and bile salt concentration of the medium to study the inhibitory ability of XOD and the acid and alkali resistance of strains X3-2B and 37X-3 in vitro.In addition, sixty KM mice were divided into five groups, including control group (Group C), model group (Group M), X3-2B group (Group X), 37X-3 group (Group L), and allopurinol group (Group P).All groups, except for Group C, were fed high-purine chow.The mice were fed for 4 weeks, and the corresponding doses of strains X3-2B, 37X-3, and allopurinol were administered to groups X, L, and P respectively.This study investigated the mitigating effects of strains X3-2B and 37X-3 on HUA in mice by analyzing physiological and biochemical indexes, renal pathology sections, and intestinal tissues of the mice for XOD activity.Results showed that strains X3-2B and 37X-3 effectively inhibited XOD-catalyzed xanthine production of UA.At pH 2 and bile salt addition of 0.3%, the viable bacterial counts of X3-2B and 37X-3 were 6.4×107 CFU/g (X3-2B), 9.3×107 CFU/g (37X-3), and 2.1×106 CFU/g (X3-2B), 2.8×106 CFU/g (37X-3) respectively.After four weeks of feeding, there was a significant decrease in serum levels of UA, BUN, and Cr in mice in groups X and L (P<0.05).The renal units were structurally intact, and the activity of XOD in intestinal tissues was inhibited (P<0.05).The study concluded that strains X3-2B and 37X-3 were able to effectively inhibit XOD activity and reduce UA production.Furthermore, these strains were found to exert XOD inhibition function in the intestinal tract of HUA mice and alleviate HUA in mice.

参考文献

[1] 崔佳佳. 尿酸盐晶体形态学及果糖对尿酸转运子影响的研究[D].泰安:泰山医学院, 2010.
CUI J J.Study of the morphological changes of urate ctystals and effect of fructose to the urate transporter[D].Taian:Taishan Medical University, 2010.
[2] WANG Z, CUI T, CI X Y, et al.The effect of polymorphism of uric acid transporters on uric acid transport[J].Journal of Nephrology, 2019, 32(2):177-187.
[3] 蓝淑珍, 周恩超.高尿酸血症对慢性肾脏病影响的研究进展[J].中国临床新医学, 2022, 15(9):878-882.
LAN S Z, ZHOU E C.Research progress in the effect of hyperuricemia on chronic kidney disease[J].Chinese Journal of New Clinical Medicine, 2022, 15(9):878-882.
[4] HUANG J Y, MA Z F, ZHANG Y T, et al.Geographical distribution of hyperuricemia in mainland China:A comprehensive systematic review and meta-analysis[J].Gloabl Health Research and Policy, 2020, 5(1):52-52.
[5] BOHATÁ J, HORVÁTHOVÁ V, PAVLÍKOVÁ M, Et al.Circulating microRNA alternations in primary hyperuricemia and gout[J].Arthritis Research & Therapy, 2021, 23(1):186.
[6] RUAN F K, LIU C Q, HU W P, et al.Early life PCB138 exposure induces kidney injury secondary to hyperuricemia in male mice[J].Environmental Pollution, 2022, 301:118977.
[7] LI Y K, LI H Q, WANG R, et al.Protective effect of sodium butyrate on intestinal barrier damage and uric acid reduction in hyperuricemia mice[J].Biomedicine & Pharmacotherapy, 2023, 161:114568.
[8] WANG F Q, ZHAO X, SU X, et al.Isorhamnetin, the xanthine oxidase inhibitor from Sophora japonica, ameliorates uric acid levels and renal function in hyperuricemic mice[J].Food & Function, 2021, 12(24):12503-12512.
[9] DALBETH N, CHOI H K, JOOSTEN L A B, et al.Gout[J].Nature Reviews Disease Primers, 2019, 5:69.
[10] LIU X P, ZHANG Z J, ZHANG Y, et al.Artificial metalloenzyme-based enzyme replacement therapy for the treatment of hyperuricemia[J].Advanced Functional Materials, 2016, 26(43):7921-7928.
[11] ZHANG L, ZHANG C, ZHUANG Z N, et al.Bio-inspired nanoenzyme for metabolic reprogramming and anti-inflammatory treatment of hyperuricemia and gout[J].Science China Chemistry, 2021, 64(4):616-628.
[12] 张丽萍, 杨建雄.生物化学简明教程[M].北京:高等教育出版社, 2015.
ZHANG L P, YANG J X.A Concise Course in Biochemistry[M].Beijing:Higher Education Press, 2015.
[13] DA SILVA T F, CASAROTTI S N, DE OLIVEIRA G L V, et al.The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts[J].Critical Reviews in Food Science and Nutrition, 2021, 61(2):337-355.
[14] OAK S J, JHA R.The effects of probiotics in lactose intolerance:A systematic review[J].Critical Reviews in Food Science and Nutrition, 2019, 59(11):1675-1683.
[15] LIANG X, LV Y Y, ZHANG Z, et al.Study on intestinal survival and cholesterol metabolism of probiotics[J].LWT, 2020, 124:109132.
[16] JOHNSTON B C, GOLDENBERG J Z, PARKIN P C, et al.Probiotics and the prevention of antibiotic-associated diarrhea in infants and children[J].JAMA, 2016, 316(14):1484-1485.
[17] WANG H, LEE I-S, BRAUN C, et al.Effect of probiotics on central nervous system functions in animals and humans:A systematic review[J].Journal of Neuroga stroenterology and Motility, 2016, 22(4):589-605.
[18] DING S J, HU C, FANG J, et al.The protective role of probiotics against colorectal cancer[J].Oxidative Medicine and Cellular Longevity, 2020, 2020(1):8884583.
[19] SEHRAWAT N, YADAV M, SINGH M, et al.Probiotics in microbiome ecological balance providing a therapeutic window against cancer[J].Seminars in Cancer Biology, 2021, 70:24-36.
[20] CAO J Y, WANG T, LIU Y S, et al.Lactobacillus fermentum F40-4 ameliorates hyperuricemia by modulating the gut microbiota and alleviating inflammation in mice[J].Food & Function, 2023, 14(7):3259-3268.
[21] MEI Z J, LI D D.The role of probiotics in vaginal health[J].Frontiers in Cellular and Infection Microbiology, 2022, 12:963868.
[22] RAWAL S, ALI S A.Probiotics and postbiotics play a role in maintaining dermal health[J].Food & Function, 2023, 14(9):3966-3981.
[23] YAMADA N, IWAMOTO C, KANO H, et al.Evaluation of purine utilization by Lactobacillus gasseri strains with potential to decrease the absorption of food-derived purines in the human intestine[J].Nucleosides, Nucleotides & Nucleic Acids, 2016, 35(10-12):670-676.
[24] XIAO Y X, ZHANG C X, ZENG X L, et al.Microecological treatment of hyperuricemia using Lactobacillus from pickles[J].BMC Microbiology, 2020, 20(1):195.
[25] 倪彩新. 乳杆菌对高尿酸血症的影响及作用途径探究[D].无锡:江南大学, 2021.
NI C X.Study of the effects and approaches of Lactobacillus on hyperuricaemia alleviation[D].Wuxi:Jiangnan University, 2021.
[26] 刘慧敏. 乳酸菌嘌呤降解菌株的筛选、基因组特征及其应用研究[D].扬州:扬州大学, 2021.
LIU H M.Screening, genomic characteristics and application of purine degrading lactic acid bacteria[D]. Yangzhou:Yangzhou University, 2021.
[27] ZHANG X P, WANG J J, WU Q H, et al.Determination of kanamycin by high performance liquid chromatography[J].Molecules, 2019, 24(10):1902.
[28] WIJEMANNE N, SOYSA P, WIJESUNDARA S, et al.Development and validation of a simple high performance liquid chromatography/UV method for simultaneous determination of urinary uric acid, hypoxanthine, and creatinine in human urine[J].International Journal of Analytical Chemistry, 2018, 2018:1647923.
[29] JIANG S Y, SONG D N, ZHAO H H, et al.Bioactivity and component analysis of water extract of Sophora japonica against hyperuricemia by inhibiting xanthine oxidase activity[J].Foods, 2022, 11(23):3772.
[30] EBEFORS K, BERGWALL L, NYSTRÖM J.The Glomerulus according to the mesangium[J].Frontiers in Medicine, 2022, 8:740527.
[31] PENG R, LIU K, LI W D, et al.Blood urea nitrogen, blood urea nitrogen to creatinine ratio and incident stroke:The Dongfeng-Tongji cohort[J].Atherosclerosis, 2021, 333:1-8.
[32] WANG S, WANG F, WANG X, et al.Elevated creatinine clearance in lupus nephritis patients with normal creatinine[J].International Journal of Medical Sciences, 2021, 18(6):1449-1455.
[33] SUN X W, WEN J, GUAN B S, et al.Folic acid and zinc improve hyperuricemia by altering the gut microbiota of rats with high-purine diet-induced hyperuricemia[J].Frontiers in Microbiology, 2022, 13:907952.
[34] DHOUIBI R, AFFES H, SALEM M B, et al.Creation of an adequate animal model of hyperuricemia (acute and chronic hyperuricemia);study of its reversibility and its maintenance[J].Life Sciences, 2021, 268:118998.
[35] BHOLE V, CHOI J W J, KIM S W, et al.Serum uric acid levels and the risk of type 2 diabetes:A prospective study[J].The American Journal of Medicine, 2010, 123(10):957-961.
[36] 杨殿斌.降血尿酸乳酸菌筛选及乳杆菌对高血尿酸血症大鼠作用的研究[D].大连:大连医科大学, 2013.
YANG D B.The screening of lactobacillus reduced blood uric acid and lactobacillus′ effect in hyperuricemia rat model[D].Dalian:Dalian Medical University, 2013.
[37] 邓英. 乳杆菌对高果糖诱导小鼠高尿酸血症的防治作用及机制探讨[D].大连:大连医科大学, 2018.
DENG Y.Prevention and cure effects of Lactobacillus on hyperuricemia induced by high fructose diet and its mechanism[D].Dalian:Dalian Medical University, 2018.
[38] OOI K L, ZAKARIA R, TAN M L, et al.The influence of chemical composition of potent inhibitors in the hydrolyzed extracts of anti-hyperuricemic plants to their xanthine oxidase activities[J].Journal of ethnopharmacology, 2021, 278:114-294.
文章导航

/